Evidentic GmbH

🌟 𝗔𝗿𝗲 𝘆𝗼𝘂 𝗹𝗼𝗼𝗸𝗶𝗻𝗴 𝗳𝗼𝗿 𝘁𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰 𝗺𝗼𝗹𝗲𝗰𝘂𝗹𝗲𝘀? 💊 If so, we have just what you need! Due to special project requirements, we know sometimes the expiry date for human use is a thing. So, we decided to give you the opportunity to access the "fresh" batches from our Evidentic inventory before they become "historical". 🧬⚡️ To view our current selection of molecules and their corresponding expiration dates, please visit our website (link in the comments) or reach out to our customer support team at 📧 info@evidentic.com! 🕒 Quantities are limited, so act fast to secure the fresh molecules you need! #InnovationInMedicine #ResearchAndDevelopment #ClinicalGradeMolecules #Evidentic #Antibody #mAb #ClinicalGrade #DrugDevelopment #DrugDiscovery #Pharmaceuticals #Biotech #TherapeuticMolecules #Laboratory #BiotechSolutions #RAndD

𝗦𝗽𝗶𝗱𝗲𝗿𝘀: 𝘀𝗰𝗮𝗿𝗶𝗲𝗿 𝗼𝗿 𝘀𝗺𝗮𝗿𝘁𝗲𝗿? 🕷️🎃 Forget about ghosts and ghouls, it turns out, spiders have more tricks up their sleeves than just those creepy webs. Beyond the neurotoxins we already knew about, scientists at the LOEWE-Zentrum für Translationale Biodiversitätsgenomik (TBG) and Fraunhofer-Institut für Molekularbiologie und Angewandte Oekologie found a treasure trove of enzymes that could be game-changers for industries like cleaning products. Imagine a world where our laundry detergent is powered by spider enzymes! 🧪 This groundbreaking research shows that there's still so much to discover about these fascinating creatures. At Evidentic GmbH, we're excited about the potential of this research to drive innovation in sustainable technologies. As a company dedicated to evidence-based solutions, we're eager to see how this research can be translated into practical applications that benefit both people and the planet. 🌍 Read the full article: https://lnkd.in/d9jEnCew What do you think is the coolest thing about this discovery? 🤔 #biotechnology #greenchemistry #spidervenom #sustainability #innovation #ResearchAndDevelopment 

🏡 𝗡𝗲𝘄 𝗛𝗼𝗺𝗲, 𝗦𝗮𝗺𝗲 𝗛𝗶𝗴𝗵-𝗤𝘂𝗮𝗹𝗶𝘁𝘆 𝗦𝗲𝗿𝘃𝗶𝗰𝗲! ✨   Welcome to our new office at GO:IN 2 in Potsdam! 🎉   We did it! We've officially moved and are excited to share the news. 🙌   📍𝗪𝗵𝗮𝘁 𝗱𝗼𝗲𝘀 𝘁𝗵𝗶𝘀 𝗺𝗲𝗮𝗻 𝗳𝗼𝗿 𝘆𝗼𝘂? More control, more personalized support, and more efficiency through…   ✅ In-house aliquotation in our high-quality service lab ✅ New team members: Andrea in Sales and Diana in the lab 👩🔬👩💼 ✅ Streamlined processes to meet your needs and deliver top-tier service 💯   Our new facility will handle everything—from sourcing and aliquoting to shipping—ensuring unmatched efficiency, quality, and reliability. With this move, we’re taking full control of the process, all under one roof. 🏢🚀   📍 𝗡𝗲𝘄 𝗔𝗱𝗱𝗿𝗲𝘀𝘀: Evidentic GmbH Am Mühlenberg 10 14476 Potsdam, Germany   We look forward to welcoming you to our new home! 🏡 Whether you're seeking innovative solutions or want to discuss your research goals, we're here to help you succeed. Reach out anytime! 💬💡   📍𝗟𝗼𝗼𝗸𝗶𝗻𝗴 𝗳𝗼𝗿 𝗿𝗲𝗰𝗼𝗺𝗺𝗲𝗻𝗱𝗮𝘁𝗶𝗼𝗻𝘀! What are your must-see spots in Potsdam? 🧐 And where’s the best place to grab a team lunch or host a workshop? 🍽️ 🏢 #Potsdam #Recommendations #TeamBuilding #LunchSpot #WorkshopVenue   #BiopharmaSolutions #BiotechInnovation #EvidenticTeam #QualityService #ScientificExcellence #LabLife #ResearchGoals #HealthcareInnovation 🌍🔬⚗️

💰 𝗡𝗲𝘄 𝗧𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀 𝗳𝗼𝗿 𝗗𝗟𝗕𝗖𝗟: 𝗣𝗿𝗶𝗰𝗲 𝗗𝗿𝗼𝗽 𝗳𝗼𝗿 𝗟𝗼𝗻𝗰𝗮𝘀𝘁𝘂𝘅𝗶𝗺𝗮𝗯 𝗧𝗲𝘀𝗶𝗿𝗶𝗻! 💊 The landscape for Diffuse Large B-cell Lymphoma (DLBCL) treatment is evolving with multiple new therapies entering the market. While Zynlonta® (Loncastuximab Tesirin) remains a valuable tool in oncology, we understand the importance of cost-effective solutions for our customers.🎯 💡 𝗪𝗵𝗮𝘁 𝗱𝗼𝗲𝘀 𝘁𝗵𝗶𝘀 𝗺𝗲𝗮𝗻 𝗳𝗼𝗿 𝘆𝗼𝘂? At Evidentic, we're committed to providing licensed therapeutics in smaller units (aliquots) at competitive prices. We can now offer Zynlonta® aliquots at 𝗼𝘃𝗲𝗿 𝟯𝟬% 𝗹𝗲𝘀𝘀 than before, ensuring you get licensed molecules while saving on costs.💰 Though Zynlonta is not currently in stock, our on-demand procurement ensures quick and efficient delivery 🚚. Looking for alternatives? We've also got a small amount of historical aliquots of Polatuzumab Vedotin (Polivy®), another key therapy in the DLBCL arsenal. 𝗛𝗲𝗿𝗲'𝘀 𝘄𝗵𝗮𝘁 𝘆𝗼𝘂 𝗰𝗮𝗻 𝗲𝘅𝗽𝗲𝗰𝘁 𝗳𝗿𝗼𝗺 𝗘𝘃𝗶𝗱𝗲𝗻𝘁𝗶𝗰: 💸 Competitive Pricing: Access critical research molecules at a lower cost. 🧪 Rare & Historical Aliquots: Unique resources for hard-to-find molecules. 🔄 Seamless Sourcing: Sourced directly from original therapeutics for guaranteed quality. 👩🔬 Expert Support: Our team is here to guide you through your sourcing needs. 🚀 𝗥𝗲𝗮𝗱𝘆 𝘁𝗼 𝗲𝘅𝗽𝗹𝗼𝗿𝗲 𝗳𝘂𝗿𝘁𝗵𝗲𝗿? Contact @Susann, our Operations Manager, or visit our website for analytical data and drug aliquots (Link in comments). There you can browse our online shop for Zynlonta® and a wide range of other licensed molecules.🛒 Stay tuned! We’re constantly adding new solutions to help power your research and early drug development. #ClinicalResearch #DrugDevelopment #Biotech #ResearchMolecules #Evidentic #GlobalAccess #MoleculeSupply #InnovationInScience

🦀𝗗𝗶𝘃𝗶𝗻𝗴 𝗗𝗲𝗲𝗽 𝗳𝗼𝗿 𝗮 𝗗𝗿𝘂𝗴 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆: 𝗡𝗲𝘄 𝗧𝗼𝘅𝗶𝗻𝘀 𝗳𝗿𝗼𝗺 𝗖𝗮𝘃𝗲-𝗗𝘄𝗲𝗹𝗹𝗶𝗻𝗴 𝗖𝗿𝘂𝘀𝘁𝗮𝗰𝗲𝗮𝗻𝘀 🧪 Imagine a world where drugs for neurological diseases like epilepsy could be inspired by creatures found in ancient Mayan caves. That's exactly what a team of scientists has discovered! They've identified novel toxins from a cave-dwelling crustacean that could revolutionize treatment options. These tiny creatures, found exclusively in the sacred Mayan cenotes, produce toxins that target specific ion channels in our bodies. This unique discovery opens up exciting new possibilities for drug development. For us, the potential of research like this to drive innovation in medicine seems huge. The discovery of new toxins highlights the importance of exploring diverse ecosystems for potential therapeutic applications. As a company dedicated to evidence-based solutions, we're eager to see how this research can be translated into life-changing treatments. Read the full article: https://lnkd.in/diVgN_ug. Any concerns about the ethical implications of using animal-derived toxins in medical research? 🤔 #biodiversity #drugdiscovery #marinebiology #neurology #epilepsy #research #science #innovation #pharma #biotech #ResearchAndDevelopment

💊 𝐋𝐨𝐰 𝐢𝐧 𝐒𝐭𝐨𝐜𝐤 𝐑𝐞𝐟𝐞𝐫𝐞𝐧𝐜𝐞 𝐒𝐭𝐚𝐧𝐝𝐚𝐫𝐝𝐬! 🛒   🧪 In early drug development, researchers deal with some challenges. Don't let the access to licensed molecules be one of them.   If you're in need of small units from licensed drugs, we've got you covered. Take a look at our current selection of rare drug aliquots and see if any of our unique batches align with your research project. Additionally, we introduce the historical batches of the rare molecules that are almost out of stock and cannot be replaced. 📦💊   We encourage you to act quickly before they sell out completely. Check our online shop link in the comments! 🛒🔬   #InnovationInMedicine #ResearchAndDevelopment #ClinicalGradeMolecules #Evidentic #Antibody #mAb #ClinicalGrade #DrugDevelopment #DrugDiscovery

🚨𝗚𝗲𝘁 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹-𝗴𝗿𝗮𝗱𝗲 𝗣𝗲𝗺𝗯𝗿𝗼𝗹𝗶𝘇𝘂𝗺𝗮𝗯💉   … from the original Keytruda® commercial drug at Evidentic! 🌐   Visit our online shop (link in the comments) to access this essential research molecule and explore our extensive batch library, featuring other licensed molecules from original therapeutics. 📊💊   Evidentic offers global access, reliable sourcing, and research benefits. Don't miss this opportunity to advance your research! 🧬🔬   #Pembrolizumab #Keytruda #ClinicalResearch #DrugDevelopment #Biotech #ResearchMolecules #Evidentic #GlobalAccess #MoleculeSupply #InnovationInScience

🌟 Are you looking for therapeutic molecules? 💊   If so, we have just what you need!   Due to special project requirements, we know sometimes the expiry date for human use is a thing. So, we decided to give you the opportunity to access the "fresh" batches from our Evidentic inventory before they become "historical". 🧬⚡️   To view our current selection of molecules and their corresponding expiration dates, please visit our website (link in the comments) or reach out to our customer support team at 📧 info@evidentic.com! 🕒 Quantities are limited, so act fast to secure the fresh molecules you need!   #InnovationInMedicine #ResearchAndDevelopment #ClinicalGradeMolecules #Evidentic #Antibody #mAb #ClinicalGrade #DrugDevelopment #DrugDiscovery #Pharmaceuticals #Biotech #TherapeuticMolecules #Laboratory #BiotechSolutions #MoleculeSupply #RAndD

💊 𝐋𝐨𝐰 𝐢𝐧 𝐒𝐭𝐨𝐜𝐤 𝐑𝐞𝐟𝐞𝐫𝐞𝐧𝐜𝐞 𝐒𝐭𝐚𝐧𝐝𝐚𝐫𝐝𝐬! 🛒   🧪 In early drug development, researchers deal with some challenges. Don't let the access to licensed molecules be one of them.   If you're in need of small units from licensed drugs, we've got you covered. Take a look at our current selection of rare drug aliquots and see if any of our unique batches align with your research project. Additionally, we introduce the historical batches of the rare molecules that are almost out of stock and cannot be replaced. 📦💊   We encourage you to act quickly before they sell out completely. Check our online shop link in the comments! 🛒🔬   #InnovationInMedicine #ResearchAndDevelopment #ClinicalGradeMolecules #Evidentic #Antibody #mAb #ClinicalGrade #DrugDevelopment #DrugDiscovery

🧠 𝗔𝗹𝘇𝗵𝗲𝗶𝗺𝗲𝗿'𝘀 𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁: 𝗔 𝗡𝗲𝘄 𝗛𝗼𝗽𝗲 𝗳𝗼𝗿 𝗣𝗮𝘁𝗶𝗲𝗻𝘁𝘀   The race to find effective treatments for Alzheimer's disease has produced mixed results. While the FDA has approved Aducanumab (Aduhelm®), Lecanemab (Leqmbi®), and Donanemab (Kisunla®), the European Medicines Agency (EMA) is taking a more cautious approach. ⚖️   Donanemab (Kisunla®), another promising monoclonal antibody targeting amyloid plaques, has shown promise in slowing cognitive decline in Alzheimer's patients. Approved by the FDA in 2024, it's currently under review by the EMA.   𝗡𝗲𝗲𝗱 𝗗𝗼𝗻𝗮𝗻𝗲𝗺𝗮𝗯 𝗳𝗼𝗿 𝗬𝗼𝘂𝗿 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵? 🛒 Evidentic is your sourcing specialist for licensed Donanemab, sourced directly from the original Kisunla®, and other top-quality clinical-grade molecules. 🧬 Check our online shop (link in the comments) and discover the potential of clinical-grade molecules to improve research outcomes!   #Alzheimers #Kisunla #FDA #EMA #Neuroscience #Evidentic #MonoclonalAntibodies #MABs #ClinicalGrade #DrugDevelopment #DrugDiscovery #MedicalResearch #Pharmaceuticals #ResearchandDevelopment